Toggle Dropdown
Groups
Announcements
Projects
Welcome guest
Log in
Friends
Loading
Loading...
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00019-4/fulltext
0
0
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium - The Lancet
2/14/23 at 6:30am
Organization
The Lancet
56 words
0
Comments
Vaccination against COVID-19, especially with additional doses, is a fundamental strategy in the prevention of adverse outcomes including death, among patients with cancer.
Health Conditions
Health
Breakthrough SARS-CoV
COVID
mRNA
Cancer Consortium
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...